Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SiMPLInext SA logo — Tools to foster industrial applicability and acceptance of i...

SiMPLInext SA

Tools to foster industrial applicability and acceptance of in vitro

Founded 2016 Switzerland Switzerland 1 employees Unknown Health Care

General Information

Company Name SiMPLInext SA
Founded Year 2016
Location Switzerland Switzerland +1
Employees 1
Industries Health Care
Funding Stage Unknown
Social

Get notified when SiMPLInext SA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SiMPLInext SA

SiMPLInext SA seeks to revolutionize the field of advanced cell culture. Known for its dedication to enhancing industrial applicability of in vitro models, the company offers an innovative solution to unreliable conventional tissue models.

Their proprietary cell culture inserts serve as a direct replacement, notably improving reliability, relevance, and reproducibility of data in in vitro testing. This breakthrough enables toxicologists and drug designers to gain deeper insights into biological barriers without altering existing protocols.

Founded in 2016 and headquartered in Switzerland, SiMPLInext SA has thus far engaged in modest financial activity, with their last known funding being a Fr.20.00K grant investment from Venture Kick on 16 September 2015. As the health care industry continues to prioritize more accurate and reliable testing models, SiMPLInext stands ready to meet this demand with its cutting-edge technology.

Taxonomy: advanced cell culture, in vitro models, biological barriers, drug testing, toxicology, reproducibility, data quality, cell culture inserts, biological relevance, process improvement, research innovation, ergonomic design, in situ measurement, scientific instrumentation, life sciences

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 01 Mar 2023

SiMPLInext SA Alternatives & Competitors

SiMPLInext SA vs
BioLamina
BioLamina Sweden

Cell-specific culture matrices for improved cell functionality

Loan
120 employees
Biotechnology
SiMPLInext SA vs
3D Genomics
3D Genomics United States

We work with you to design the study, build the best cell models and develop informative data analys...

1 employees
Biopharma, Biotechnology
SiMPLInext SA vs
Celogics
Celogics United States

Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutical research

3 employees
Biotechnology, Manufacturing

FAQ About SiMPLInext SA

Tools to foster industrial applicability and acceptance of in vitro
SiMPLInext SA was founded in 2016.
SiMPLInext SA is headquartered in Switzerland.
SiMPLInext SA operates in the following industries: Health Care.
SiMPLInext SA has approximately 1 employees.
SiMPLInext SA has completed 1 funding round. The latest funding stage is Unknown.
Top alternatives and competitors to SiMPLInext SA include BioLamina, 3D Genomics , Celogics, Bi/ond, mo:re. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SiMPLInext SA and BioLamina are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SiMPLInext SA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy